148 related articles for article (PubMed ID: 23551178)
21. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
[TBL] [Abstract][Full Text] [Related]
22. Localisation of citrullinated proteins in normal appearing white matter and lesions in the central nervous system in multiple sclerosis.
Bradford CM; Ramos I; Cross AK; Haddock G; McQuaid S; Nicholas AP; Woodroofe MN
J Neuroimmunol; 2014 Aug; 273(1-2):85-95. PubMed ID: 24907905
[TBL] [Abstract][Full Text] [Related]
23. Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis.
Dev KK; Mullershausen F; Mattes H; Kuhn RR; Bilbe G; Hoyer D; Mir A
Pharmacol Ther; 2008 Jan; 117(1):77-93. PubMed ID: 17961662
[TBL] [Abstract][Full Text] [Related]
24. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors.
Osinde M; Mullershausen F; Dev KK
Neuropharmacology; 2007 Apr; 52(5):1210-8. PubMed ID: 17379261
[TBL] [Abstract][Full Text] [Related]
26. Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors.
Bassi R; Anelli V; Giussani P; Tettamanti G; Viani P; Riboni L
Glia; 2006 Apr; 53(6):621-30. PubMed ID: 16470810
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.
Sinclair C; Mirakhur M; Kirk J; Farrell M; McQuaid S
Neuropathol Appl Neurobiol; 2005 Jun; 31(3):292-303. PubMed ID: 15885066
[TBL] [Abstract][Full Text] [Related]
28. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression.
Kitano M; Hla T; Sekiguchi M; Kawahito Y; Yoshimura R; Miyazawa K; Iwasaki T; Sano H; Saba JD; Tam YY
Arthritis Rheum; 2006 Mar; 54(3):742-53. PubMed ID: 16508938
[TBL] [Abstract][Full Text] [Related]
29. Impact of sphingosine 1-phosphate modulation on immune outcomes.
Pinschewer DD; Brinkmann V; Merkler D
Neurology; 2011 Feb; 76(8 Suppl 3):S15-9. PubMed ID: 21339486
[TBL] [Abstract][Full Text] [Related]
30. Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease.
van der Giet M; Tölle M; Kleuser B
Biol Chem; 2008 Nov; 389(11):1381-90. PubMed ID: 18925828
[TBL] [Abstract][Full Text] [Related]
31. Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1P
Kihara Y; Jonnalagadda D; Zhu Y; Ray M; Ngo T; Palmer C; Rivera R; Chun J
FASEB J; 2022 Feb; 36(2):e22132. PubMed ID: 34986275
[TBL] [Abstract][Full Text] [Related]
32. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels.
Cunnea P; McMahon J; O'Connell E; Mashayekhi K; Fitzgerald U; McQuaid S
Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542
[TBL] [Abstract][Full Text] [Related]
33. Amyloid precursor protein (APP) expression in multiple sclerosis lesions.
Gehrmann J; Banati RB; Cuzner ML; Kreutzberg GW; Newcombe J
Glia; 1995 Oct; 15(2):141-51. PubMed ID: 8567065
[TBL] [Abstract][Full Text] [Related]
34. Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling.
Zeis T; Allaman I; Gentner M; Schroder K; Tschopp J; Magistretti PJ; Schaeren-Wiemers N
Brain Behav Immun; 2015 Aug; 48():313-25. PubMed ID: 25937052
[TBL] [Abstract][Full Text] [Related]
35. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
[TBL] [Abstract][Full Text] [Related]
36. Roles for HB-EGF and CD9 in multiple sclerosis.
Schenk GJ; Dijkstra S; van het Hof AJ; van der Pol SM; Drexhage JA; van der Valk P; Reijerkerk A; van Horssen J; de Vries HE
Glia; 2013 Nov; 61(11):1890-905. PubMed ID: 24038577
[TBL] [Abstract][Full Text] [Related]
37. Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
Jin J; Hu J; Zhou W; Wang X; Xiao Q; Xue N; Yin D; Chen X
Biochem Pharmacol; 2014 Jul; 90(1):50-61. PubMed ID: 24780445
[TBL] [Abstract][Full Text] [Related]
38. Alpha-smooth muscle actin (alpha-SMA) and nestin expression in reactive astrocytes in multiple sclerosis lesions: potential regulatory role of transforming growth factor-beta 1 (TGF-beta1).
Moreels M; Vandenabeele F; Dumont D; Robben J; Lambrichts I
Neuropathol Appl Neurobiol; 2008 Oct; 34(5):532-46. PubMed ID: 18005096
[TBL] [Abstract][Full Text] [Related]
39. Butyrylcholinesterase activity in multiple sclerosis neuropathology.
Darvesh S; Leblanc AM; Macdonald IR; Reid GA; Bhan V; Macaulay RJ; Fisk JD
Chem Biol Interact; 2010 Sep; 187(1-3):425-31. PubMed ID: 20122907
[TBL] [Abstract][Full Text] [Related]
40. Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions.
Witte ME; Bol JG; Gerritsen WH; van der Valk P; Drukarch B; van Horssen J; Wilhelmus MM
Neurobiol Dis; 2009 Dec; 36(3):445-52. PubMed ID: 19716418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
